TW202417009A - Pharmaceutical formulations and uses thereof - Google Patents

Pharmaceutical formulations and uses thereof Download PDF

Info

Publication number
TW202417009A
TW202417009A TW112141111A TW112141111A TW202417009A TW 202417009 A TW202417009 A TW 202417009A TW 112141111 A TW112141111 A TW 112141111A TW 112141111 A TW112141111 A TW 112141111A TW 202417009 A TW202417009 A TW 202417009A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical formulations
tablets
lubricant
filler
iii
Prior art date
Application number
TW112141111A
Other languages
Chinese (zh)
Inventor
金伯利 T 巴雷特
伊蓮 班揚
Original Assignee
美商基利科學股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商基利科學股份有限公司 filed Critical 美商基利科學股份有限公司
Publication of TW202417009A publication Critical patent/TW202417009A/en

Links

Abstract

Pharmaceutical formulations, particularly solid oral dosage forms (e.g., tablets) comprising (i) the compound of Formula I in an amount of about 40 wt% to about 70 wt%, (ii) a filler, (iii) a disintegrating agent, (iv) and a lubricant are disclosed, as are uses thereof.
TW112141111A 2022-10-27 2023-10-26 Pharmaceutical formulations and uses thereof TW202417009A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/381,272 2022-10-27
US63/508,567 2023-06-16

Publications (1)

Publication Number Publication Date
TW202417009A true TW202417009A (en) 2024-05-01

Family

ID=

Similar Documents

Publication Publication Date Title
HK1076605A1 (en) Formulations
MY148773A (en) Galenic formulations of organic compounds
TN2012000246A1 (en) Pharmaceutical compositions comprising sigma receptor ligands
PL1750862T3 (en) Pharmaceutical composition containing irbesartan
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
CO5390076A1 (en) PHARMACEUTICAL COMPOSITIONS
TW200503775A (en) Pharmaceutical composition and method for treating
UA116334C2 (en) SOLID FORMS OF BENDAMUSTINE DOSAGE
WO2008023016A3 (en) Galenic formulations of aliskiren
RS20110136A1 (en) Compositions comrrising amlodipine and bisoprolol
MXPA04005104A (en) Dosage regimen and pharmaceutical composition for emergency contraception.
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
UA92498C2 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
WO2010046933A3 (en) Pharmaceutical compositions of taste-masked linezolid
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
ATE418540T1 (en) GALLOYL PEPTIDES
TW202417009A (en) Pharmaceutical formulations and uses thereof
TW200640472A (en) Solid pharmaceutical composition comprising telithromycin
MY148266A (en) Galenical formulations of aliskiren
WO2007047881A3 (en) Method for treating neuropathic pain
JP4974526B2 (en) Composition for preventing or treating candidiasis
WO2009004039A3 (en) Hard gelatin capsule formulation comprising a pumpkin product
MXPA05008921A (en) Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier.
TW200511986A (en) Antifungal composition